Actavis Eyes Acquisitions In The Middle East And Niche Products In The U.S.

08 Sep 2010

• By The Pink Sheet Daily

The company's new CEO, Claudio Albrecht, is gearing up for growth by looking to acquire BioPartners, a biosimlars opportunity, but also on his radar are geographic expansion in Asia and the Middle East, and development of modified-release products.

Actavis Eyes Acquisitions In The Middle East And Niche Products In The U.S.

More from Archive

More from Pink Sheet